Chicago filed a lawsuit against five major producers of pharmaceutical products on Tuesday accusing the group of concealing the risks associated with certain painkillers Saying that a drug maker should never place its desire for profits above the health and wellbeing of its customers the city said that the companies knew for years that certain painalleviating drugs were addictive and could prove debilitating in the longterm The five companies named in the suit include Actavis Endo Health Solutions Janssen Pharmaceuticals a unit of Johnson  Johnson Purdue Pharma and Cephalon a division of generic drug giant Teva The suit contends that the drugs have ramped up addiction that has become a scourge in Chicago and other major cities The lengthy suit filed in a Cook County circuit court alleges that the cohort of companies misused their dominance to broaden the market for opiumlike painkillers called opoids These prescription drugs included topshelf brand names such as OxyContin and Percocet as well as a clutch of generics The drug makers spent millions of dollars funding assisting and encouraging doctors and front groups to promote the drugs and broaden their reach among users afflicted with chronic pain Chicago says The effort to flood the market was wildly successful The United States is now awash in opiods the suit said citing data showing that more than  million prescriptions for the narcotic were filled in  The suit contends that the drugs have ramped up addiction that has become a scourge in Chicago and other major cities Robyn Frenze a spokesperson for Janssen said in a statement emailed to CNBC that the company is committed to ethical business practices and responsible promotion prescribing and use of all our medications Were currently reviewing the complaint A spokesman for Actavis said the company does not comment on pending litigation Representatives for Endo Purdue and Cephalon were not immediately available to respond to requests from CNBC